Enliven Therapeutics, Inc.

ELVN Nasdaq SEC CIK 1672619

Follow Enliven Therapeutics Weekly email: filings, results, news

News

5 stories filed under Enliven Therapeutics, grouped into ongoing threads

Thread · 2 stories

Markets 37 d ago

Markets 37 d ago also on BCS

Markets 21 d ago

Markets 48 d ago 3 sources

Markets 49 d ago

NOV4

Q1 2026 results

Wednesday · estimated from the filing cadence

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 5 stories clustered from the RSS aggregator